COVERT INTRAVASCULAR CLOTTING

This publication has 11 references indexed in Scilit:

• Pathogenesis of Fibrinolysis in Defibrination Syndrome: Effect of Heparin Administration
  Blood, 1964
• PATHOGENESIS OF THE COAGULATION DEFECT DEVELOPING DURING PATHOLOGICAL PLASMA PROTEOLYTIC (“FIBRINOLYTIC”) STATES. II. THE SIGNIFICANCE, MECHANISM AND CONSEQUENCES OF DEFECTIVE FIBRIN POLYMERIZATION*
  Journal of Clinical Investigation, 1962
• PATHOGENESIS OF THE COAGULATION DEFECT DEVELOPING DURING PATHOLOGICAL PLASMA PROTEOLYTIC (“FIBRINOLYTIC”) STATES. I. THE SIGNIFICANCE OF FIBRINOGEN PROTEOLYSIS AND CIRCULATING FIBRINOGEN BREAKDOWN PRODUCTS*
  Journal of Clinical Investigation, 1962
• ACQUIRED HYPOFIBRINOGENEMIA - A REVIEW
  1962
• THE NATURE AND MECHANISM OF THE HEMOSTATIC BREAKDOWN IN THE COURSE OF EXPERIMENTAL HEMORRHAGIC SHOCK*
  Journal of Clinical Investigation, 1959
• HEMORRHAGIC STATES SECONDARY TO INTRAVASCULAR CLOTTING - AN EXPERIMENTAL STUDY OF THEIR EVOLUTION AND PREVENTION
  1958
• FIBRINOGENOPENIA COMPLICATING PREGNANCY - CLINICAL AND LABORATORY STUDIES
  1955
• The Pathogenesis of Amniotic-Fluid Embolism
  New England Journal of Medicine, 1950
• THE ACTIVE PRINCIPLE OF PLACENTAL TOXIN: THROMBOPLASTIN; ITS INACTIVATOR IN BLOOD: ANTITHROMBOPLASTIN
  American Journal of Physiology-Legacy Content, 1947
• MATERNAL PULMONARY EMBOLISM BY AMNIOTIC FLUID
  JAMA, 1941